| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/11/2014 | US8647665 Methods of treating hot flashes with formulations for transdermal or transmucosal application |
| 02/11/2014 | US8647643 Farnesoid-X-receptor antagonist as a vaccine adjuvant |
| 02/11/2014 | US8647642 Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment |
| 02/11/2014 | US8647641 Mycobacterium tuberculosis vaccine |
| 02/11/2014 | US8647640 Vaccine compositions and methods of use to protect against infectious disease |
| 02/11/2014 | US8647638 Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof |
| 02/11/2014 | US8647637 Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circulating in north american dogs |
| 02/11/2014 | US8647636 Low antigen-dose immunization utilizing overlapping peptides for maximizing T-helper cell 1 (Th1) immunity against a pathogen |
| 02/11/2014 | US8647634 Recombinant avian infectious coryza vaccine and process for preparing same |
| 02/11/2014 | US8647633 Recombinant F1-V plague vaccine |
| 02/11/2014 | US8647631 Pharmaceutical composition of an antigenic tau peptide reconstituted in a liposome and related antibodies and cell lines |
| 02/11/2014 | US8647630 Mite allergen |
| 02/11/2014 | US8647629 Powerful MHC-class II peptides derived from survivin |
| 02/11/2014 | US8647628 Peptide epitopes of apolipoprotein B |
| 02/11/2014 | US8647627 Composition for a cancer vaccine |
| 02/11/2014 | US8647626 Compositions comprising TNF-specific antibodies for oral delivery |
| 02/11/2014 | US8647625 Anti-CD154 antibodies |
| 02/11/2014 | US8647624 Treatment of immune disorders with anti-CD70 antibody |
| 02/11/2014 | US8647623 Method for treatment of blood tumor using anti-TIM-3 antibody |
| 02/11/2014 | US8647622 Humanized anti-CXCR5 antibodies, derivatives thereof and their use |
| 02/11/2014 | US8647617 Methods for modulating inflammatory and/or immune responses |
| 02/11/2014 | CA2707919C A subunit vaccine for aquaculture |
| 02/11/2014 | CA2577702C New polymorphic form of inulin and uses thereof |
| 02/11/2014 | CA2575610C Hpv vaccine comprising peptides from host cell proteins |
| 02/11/2014 | CA2564098C Solution phase biopanning method using engineered decoy proteins |
| 02/11/2014 | CA2531565C Production of poxviruses with adherent or non adherent avian cell lines |
| 02/11/2014 | CA2529496C Anti-cd74 immunoconjugates and methods |
| 02/11/2014 | CA2504956C Botulinum toxin formulations for oral administration |
| 02/11/2014 | CA2499214C Stable immunogenic product comprising antigenic heterocomplexes |
| 02/11/2014 | CA2498502C Recombinant clostridial toxin fragments with proteolytic activation |
| 02/11/2014 | CA2475993C Defective entities and uses therefor |
| 02/11/2014 | CA2471363C Albumin fusion proteins |
| 02/11/2014 | CA2469266C The method of treating cancer |
| 02/11/2014 | CA2452946C Detection and diagnosis of transmissible spongiform encephalopathies |
| 02/11/2014 | CA2421751C Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 02/11/2014 | CA2388045C Nucleic acid immunogenic compositions encoding hsp-antigen chimera |
| 02/11/2014 | CA2387184C Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 02/06/2014 | WO2014022846A1 Cancer biomarkers and methods of use thereof |
| 02/06/2014 | WO2014022835A2 PEPTIDE VACCINES BASED ON THE EGFRvIII SEQUENCE FOR THE TREATMENT OF TUMORS |
| 02/06/2014 | WO2014022830A2 Human papilloma virus as predictor of cancer prognosis |
| 02/06/2014 | WO2014022784A2 Humanized single-chain antibody against beta 3 integrin for the treatment and prevention of metastasis |
| 02/06/2014 | WO2014022759A1 Agents that modulate immune cell activation and methods of use thereof |
| 02/06/2014 | WO2014022680A1 Anti-etbr antibodies and immunoconjugates |
| 02/06/2014 | WO2014022612A1 Combination therapy |
| 02/06/2014 | WO2014022592A1 Antibodies or fusion proteins multimerized via cysteine mutation and a mu tailpiece |
| 02/06/2014 | WO2014022572A1 Probiotic for amelioration of coccidiosis vaccine reaction |
| 02/06/2014 | WO2014022332A1 Modulation of the immune response |
| 02/06/2014 | WO2014022185A2 Method to treat or prevent herpesvirus infections |
| 02/06/2014 | WO2014022138A2 Live and in-vivo tumor specific cancer vaccine system developed by co-administration of either at least two or all three of the following components such as tumor cells, an oncolytic virus vector with transgenic expression of gm-csf and an immune checkpoint modulator |
| 02/06/2014 | WO2014021844A1 Alkyl ether compositions and methods of use |
| 02/06/2014 | WO2014021693A2 Novel monoclonal antibody which is specifically bound to tm4sf5 protein and use thereof |
| 02/06/2014 | WO2014021339A1 Monoclonal antibody against human midkine |
| 02/06/2014 | WO2014020922A1 Antibody and functional fragment thereof capable of treating diseases associated with hematopoietic stem cell transplantation such as graft-versus-host disease, and pharmaceutical composition comprising same |
| 02/06/2014 | WO2014020354A1 Campylobacter bacteria and detection |
| 02/06/2014 | WO2014020291A2 Mutant strains of neospora and uses thereof |
| 02/06/2014 | WO2014020290A2 Use of attenuated strains of parasites for the prevention or treatment of pathologies associated with an apicomplexan |
| 02/06/2014 | WO2014020218A1 Vaccine against infestations caused by blood-sucking arthropods |
| 02/06/2014 | WO2014020179A1 Novel allergen from ragweed pollen and uses thereof |
| 02/06/2014 | WO2014020062A1 Novel anti-plasmodium parasite antibodies |
| 02/06/2014 | WO2014019718A1 Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine |
| 02/06/2014 | WO2014005153A9 Methods for treating mds1-evi1 mediated cancer |
| 02/06/2014 | WO2013188755A3 Compositions and methods for non-invasive detection and treatment of hypoxic cells in vivo |
| 02/06/2014 | WO2013188627A3 Cationic lipid vaccine compositions and methods of use |
| 02/06/2014 | WO2013181087A3 Multimeric complexes with improved in vivo stability, pharmacokinetics and efficacy |
| 02/06/2014 | WO2013170367A8 Methods and uses for proprotein convertase subtilisin kexin 9 (pcsk9) inhibitors |
| 02/06/2014 | WO2013166594A8 Heteromultimer constructs of immunoglobulin heavy chains with mutations in the fc domain |
| 02/06/2014 | WO2013004076A8 Agr2 blocking antibody and use thereof |
| 02/06/2014 | US20140039121 Preparation of Polyphosphazene Microspheres |
| 02/06/2014 | US20140039017 Therapeutic combination |
| 02/06/2014 | US20140037716 Immunogenic composition for immune system modulation and use thereof, method for treating and preventing diseases, method for inducing cell regeneration and method for restoring immune response |
| 02/06/2014 | US20140037700 Composition and Method for Enhancing an Immune Response |
| 02/06/2014 | US20140037694 Adjuvant for transdermal or transmucosal administration and pharmaceutical preparation containing same |
| 02/06/2014 | US20140037692 Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase |
| 02/06/2014 | US20140037691 Vaccine composition containing synthetic adjuvant |
| 02/06/2014 | US20140037689 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
| 02/06/2014 | US20140037688 Materials and Methods for Treating Conditions Associated with Pathogenic Biofilm |
| 02/06/2014 | US20140037687 Exopolysaccharide of shigella sonnei bacteria, method for producing same, vaccine and pharmaceutical composition containing same |
| 02/06/2014 | US20140037686 Lactobacillus paracasei ncc2461 (st11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny |
| 02/06/2014 | US20140037685 Adjuvants that activate adaptive immune system by stimulating nlrp3 |
| 02/06/2014 | US20140037684 Stabilizing excipient for inactivated whole virus vaccine |
| 02/06/2014 | US20140037683 Methods of Stimulating Protective Immunity Employing Dengue Viral Antigens |
| 02/06/2014 | US20140037682 Hiv/siv vaccines for the generation of mucosal and systemic immunity |
| 02/06/2014 | US20140037680 Novel method |
| 02/06/2014 | US20140037679 Immunization of avians by administration of non-replicating vectored vaccines |
| 02/06/2014 | US20140037673 Polyvalent conjugate vaccine for cancer |
| 02/06/2014 | US20140037671 Immunogenic compositions for streptococcus pyogenes |
| 02/06/2014 | US20140037669 Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (bhs) disease |
| 02/06/2014 | US20140037668 Combination neisserial compositions |
| 02/06/2014 | US20140037666 Compositions for preventing and/or treating an infection by an hiv-1 virus |
| 02/06/2014 | US20140037658 Diagnosis and Treatment of Alzheimer's Disease |
| 02/06/2014 | US20140037654 Therapeutic method and medicament for htlv-1 associated myelopathy (ham) |
| 02/06/2014 | US20140037653 Modulation of lrch4 activity and therapeutic application thereof |
| 02/06/2014 | US20140037650 Compositions and methods related to antibodies to staphylococcal proteins isda or isdb |
| 02/06/2014 | US20140037648 Antibodies that neutralize rsv, mpv and pvm and uses thereof |
| 02/06/2014 | US20140037644 Prospective Identification and Characterization of Breast Cancer Stem Cells |
| 02/06/2014 | US20140037640 Composition comprising expression or activity inhibitors of ninjurin1 for the prevention and treatment of inflammatory disease |
| 02/06/2014 | US20140037637 Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4) |
| 02/06/2014 | US20140037635 Methods of treatment using il-17e antagonists |
| 02/06/2014 | US20140037630 Methods for treating mica-related disorders |
| 02/06/2014 | US20140037627 Modulation of pilr receptors to treat microbial infections |